IPSC   $0.5087  -0.49% Market Closed

Century Therapeutics, Inc.
Total Cash 196.40M
totalCashPerShare 2.318
EBITDA -114.72M
Total Debt 56.38M
quickRatio 10.341
currentRatio 10.618
Total Revenue 2.04M
debtToEquity 25.383
Revenue/Share 0.031
ROA -0.1924
ROE -0.55948
grossProfits
freeCashflow -62.07M
operatingCashflow -97.46M
earningsGrowth
revenueGrowth 6.788
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -45.077824
profitMargins 0.0
enterpriseValue -33.28M
forwardPE -0.7722222
floatShares 28.36M
sharesOutstanding 84.72M
sharesShort 3.33M
sharesShortPriorMonth 3.28M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.28%
heldPercentInstitutions 0.59%
Short Ratio help_outline 9.08%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 3.062
Price To Book help_outline 0.45
earningsQuarterlyGrowth
netIncomeToCommon -131.39M
trailingEps -1.90%
forwardEps -1.80%
enterpriseToEbitda 0.29
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.45 4Q 2024
institutionsCount 95
lastUpdated Nov. 7, 2024, 5:08 a.m.